nodes	percent_of_prediction	percent_of_DWPC	metapath
Cidofovir—Body temperature increased—Fludarabine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Cidofovir—Cough—Bleomycin—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Cidofovir—Angiopathy—Vincristine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cidofovir—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cidofovir—Diarrhoea—Teniposide—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cidofovir—Mediastinal disorder—Vincristine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Cidofovir—Chest pain—Bleomycin—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Cidofovir—Myalgia—Bleomycin—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Cidofovir—Alopecia—Vincristine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Cidofovir—Back pain—Carmustine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Cidofovir—Discomfort—Bleomycin—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Cidofovir—Chills—Mitoxantrone—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Cidofovir—Urine output increased—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Cidofovir—Mouth ulceration—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Cidofovir—Alopecia—Mitoxantrone—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Cidofovir—Confusional state—Bleomycin—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Cidofovir—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Cidofovir—Tremor—Carmustine—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Cidofovir—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Cidofovir—Oedema—Bleomycin—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Cidofovir—Infection—Bleomycin—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Cidofovir—Anaemia—Carmustine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Cidofovir—Back pain—Vincristine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Cidofovir—Vomiting—Teniposide—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Cidofovir—Sepsis—Methotrexate—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Cidofovir—Agitation—Carmustine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Cidofovir—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Cidofovir—Asthenia—Fludarabine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Cidofovir—Rash—Teniposide—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Cidofovir—Dermatitis—Teniposide—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Cidofovir—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Cidofovir—Headache—Teniposide—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Cidofovir—Pruritus—Fludarabine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Cidofovir—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Cidofovir—Back pain—Mitoxantrone—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Cidofovir—Leukopenia—Carmustine—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cidofovir—Anorexia—Bleomycin—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Cidofovir—Anaemia—Vincristine—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Cidofovir—Agitation—Vincristine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Cidofovir—Polyuria—Methotrexate—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Cidofovir—Hypotension—Bleomycin—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Cidofovir—Diarrhoea—Fludarabine—lymphatic system cancer	0.00106	0.00106	CcSEcCtD
Cidofovir—Convulsion—Carmustine—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Cidofovir—Hypertension—Carmustine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Cidofovir—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Cidofovir—Nausea—Teniposide—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Cidofovir—Anaemia—Mitoxantrone—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Cidofovir—Vertigo—Vincristine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Cidofovir—Leukopenia—Vincristine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Cidofovir—Myalgia—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Cidofovir—Chest pain—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Cidofovir—Anxiety—Carmustine—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Cidofovir—Paraesthesia—Bleomycin—lymphatic system cancer	0.00102	0.00102	CcSEcCtD
Cidofovir—Malaise—Mitoxantrone—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Cidofovir—Dyspnoea—Bleomycin—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Cidofovir—Renal failure acute—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Cidofovir—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Cidofovir—Convulsion—Vincristine—lymphatic system cancer	0.001	0.001	CcSEcCtD
Cidofovir—Hypertension—Vincristine—lymphatic system cancer	0.000997	0.000997	CcSEcCtD
Cidofovir—Confusional state—Carmustine—lymphatic system cancer	0.000995	0.000995	CcSEcCtD
Cidofovir—Oedema—Carmustine—lymphatic system cancer	0.000987	0.000987	CcSEcCtD
Cidofovir—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000986	0.000986	CcSEcCtD
Cidofovir—Decreased appetite—Bleomycin—lymphatic system cancer	0.000983	0.000983	CcSEcCtD
Cidofovir—Myalgia—Vincristine—lymphatic system cancer	0.000983	0.000983	CcSEcCtD
Cidofovir—Cough—Mitoxantrone—lymphatic system cancer	0.000981	0.000981	CcSEcCtD
Cidofovir—Infection—Carmustine—lymphatic system cancer	0.000981	0.000981	CcSEcCtD
Cidofovir—Vomiting—Fludarabine—lymphatic system cancer	0.000981	0.000981	CcSEcCtD
Cidofovir—Convulsion—Mitoxantrone—lymphatic system cancer	0.000974	0.000974	CcSEcCtD
Cidofovir—Rash—Fludarabine—lymphatic system cancer	0.000972	0.000972	CcSEcCtD
Cidofovir—Dermatitis—Fludarabine—lymphatic system cancer	0.000972	0.000972	CcSEcCtD
Cidofovir—Hypertension—Mitoxantrone—lymphatic system cancer	0.000971	0.000971	CcSEcCtD
Cidofovir—Pain—Bleomycin—lymphatic system cancer	0.000967	0.000967	CcSEcCtD
Cidofovir—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000966	0.000966	CcSEcCtD
Cidofovir—Headache—Fludarabine—lymphatic system cancer	0.000966	0.000966	CcSEcCtD
Cidofovir—Tachycardia—Carmustine—lymphatic system cancer	0.000963	0.000963	CcSEcCtD
Cidofovir—Myalgia—Mitoxantrone—lymphatic system cancer	0.000957	0.000957	CcSEcCtD
Cidofovir—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000957	0.000957	CcSEcCtD
Cidofovir—Chest pain—Mitoxantrone—lymphatic system cancer	0.000957	0.000957	CcSEcCtD
Cidofovir—Anxiety—Mitoxantrone—lymphatic system cancer	0.000954	0.000954	CcSEcCtD
Cidofovir—Discomfort—Mitoxantrone—lymphatic system cancer	0.000946	0.000946	CcSEcCtD
Cidofovir—Oedema—Vincristine—lymphatic system cancer	0.000942	0.000942	CcSEcCtD
Cidofovir—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000942	0.000942	CcSEcCtD
Cidofovir—Anorexia—Carmustine—lymphatic system cancer	0.000941	0.000941	CcSEcCtD
Cidofovir—Infection—Vincristine—lymphatic system cancer	0.000936	0.000936	CcSEcCtD
Cidofovir—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000932	0.000932	CcSEcCtD
Cidofovir—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00093	0.00093	CcSEcCtD
Cidofovir—Confusional state—Mitoxantrone—lymphatic system cancer	0.000925	0.000925	CcSEcCtD
Cidofovir—Nervous system disorder—Vincristine—lymphatic system cancer	0.000924	0.000924	CcSEcCtD
Cidofovir—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000923	0.000923	CcSEcCtD
Cidofovir—Hypotension—Carmustine—lymphatic system cancer	0.000922	0.000922	CcSEcCtD
Cidofovir—Oedema—Mitoxantrone—lymphatic system cancer	0.000918	0.000918	CcSEcCtD
Cidofovir—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000918	0.000918	CcSEcCtD
Cidofovir—Nausea—Fludarabine—lymphatic system cancer	0.000916	0.000916	CcSEcCtD
Cidofovir—Infection—Mitoxantrone—lymphatic system cancer	0.000912	0.000912	CcSEcCtD
Cidofovir—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000911	0.000911	CcSEcCtD
Cidofovir—Shock—Mitoxantrone—lymphatic system cancer	0.000903	0.000903	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000899	0.000899	CcSEcCtD
Cidofovir—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000899	0.000899	CcSEcCtD
Cidofovir—Urticaria—Bleomycin—lymphatic system cancer	0.000898	0.000898	CcSEcCtD
Cidofovir—Anorexia—Vincristine—lymphatic system cancer	0.000898	0.000898	CcSEcCtD
Cidofovir—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000896	0.000896	CcSEcCtD
Cidofovir—Body temperature increased—Bleomycin—lymphatic system cancer	0.000894	0.000894	CcSEcCtD
Cidofovir—Insomnia—Carmustine—lymphatic system cancer	0.000893	0.000893	CcSEcCtD
Cidofovir—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000891	0.000891	CcSEcCtD
Cidofovir—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000887	0.000887	CcSEcCtD
Cidofovir—Paraesthesia—Carmustine—lymphatic system cancer	0.000886	0.000886	CcSEcCtD
Cidofovir—Hypotension—Vincristine—lymphatic system cancer	0.000881	0.000881	CcSEcCtD
Cidofovir—Dyspnoea—Carmustine—lymphatic system cancer	0.00088	0.00088	CcSEcCtD
Cidofovir—Somnolence—Carmustine—lymphatic system cancer	0.000878	0.000878	CcSEcCtD
Cidofovir—Anorexia—Mitoxantrone—lymphatic system cancer	0.000875	0.000875	CcSEcCtD
Cidofovir—Ataxia—Methotrexate—lymphatic system cancer	0.000875	0.000875	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000859	0.000859	CcSEcCtD
Cidofovir—Decreased appetite—Carmustine—lymphatic system cancer	0.000858	0.000858	CcSEcCtD
Cidofovir—Hypotension—Mitoxantrone—lymphatic system cancer	0.000858	0.000858	CcSEcCtD
Cidofovir—Insomnia—Vincristine—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000852	0.000852	CcSEcCtD
Cidofovir—Paraesthesia—Vincristine—lymphatic system cancer	0.000846	0.000846	CcSEcCtD
Cidofovir—Constipation—Carmustine—lymphatic system cancer	0.000844	0.000844	CcSEcCtD
Cidofovir—Pain—Carmustine—lymphatic system cancer	0.000844	0.000844	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000836	0.000836	CcSEcCtD
Cidofovir—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000833	0.000833	CcSEcCtD
Cidofovir—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000824	0.000824	CcSEcCtD
Cidofovir—Decreased appetite—Vincristine—lymphatic system cancer	0.000819	0.000819	CcSEcCtD
Cidofovir—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000818	0.000818	CcSEcCtD
Cidofovir—Somnolence—Mitoxantrone—lymphatic system cancer	0.000816	0.000816	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000814	0.000814	CcSEcCtD
Cidofovir—Feeling abnormal—Carmustine—lymphatic system cancer	0.000813	0.000813	CcSEcCtD
Cidofovir—Asthenia—Bleomycin—lymphatic system cancer	0.000811	0.000811	CcSEcCtD
Cidofovir—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000808	0.000808	CcSEcCtD
Cidofovir—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000807	0.000807	CcSEcCtD
Cidofovir—Constipation—Vincristine—lymphatic system cancer	0.000806	0.000806	CcSEcCtD
Cidofovir—Pain—Vincristine—lymphatic system cancer	0.000806	0.000806	CcSEcCtD
Cidofovir—Asthma—Methotrexate—lymphatic system cancer	0.000804	0.000804	CcSEcCtD
Cidofovir—Pruritus—Bleomycin—lymphatic system cancer	0.0008	0.0008	CcSEcCtD
Cidofovir—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000798	0.000798	CcSEcCtD
Cidofovir—Pancreatitis—Methotrexate—lymphatic system cancer	0.000788	0.000788	CcSEcCtD
Cidofovir—Constipation—Mitoxantrone—lymphatic system cancer	0.000785	0.000785	CcSEcCtD
Cidofovir—Pain—Mitoxantrone—lymphatic system cancer	0.000785	0.000785	CcSEcCtD
Cidofovir—Abdominal pain—Carmustine—lymphatic system cancer	0.00078	0.00078	CcSEcCtD
Cidofovir—Body temperature increased—Carmustine—lymphatic system cancer	0.00078	0.00078	CcSEcCtD
Cidofovir—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000771	0.000771	CcSEcCtD
Cidofovir—Pancytopenia—Methotrexate—lymphatic system cancer	0.000764	0.000764	CcSEcCtD
Cidofovir—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000756	0.000756	CcSEcCtD
Cidofovir—Dysuria—Methotrexate—lymphatic system cancer	0.000752	0.000752	CcSEcCtD
Cidofovir—Neutropenia—Methotrexate—lymphatic system cancer	0.000752	0.000752	CcSEcCtD
Cidofovir—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00075	0.00075	CcSEcCtD
Cidofovir—Abdominal pain—Vincristine—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Cidofovir—Body temperature increased—Vincristine—lymphatic system cancer	0.000745	0.000745	CcSEcCtD
Cidofovir—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000734	0.000734	CcSEcCtD
Cidofovir—Urticaria—Mitoxantrone—lymphatic system cancer	0.000729	0.000729	CcSEcCtD
Cidofovir—Hypersensitivity—Carmustine—lymphatic system cancer	0.000727	0.000727	CcSEcCtD
Cidofovir—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000725	0.000725	CcSEcCtD
Cidofovir—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000725	0.000725	CcSEcCtD
Cidofovir—Pneumonia—Methotrexate—lymphatic system cancer	0.000721	0.000721	CcSEcCtD
Cidofovir—Vomiting—Bleomycin—lymphatic system cancer	0.000719	0.000719	CcSEcCtD
Cidofovir—Rash—Bleomycin—lymphatic system cancer	0.000713	0.000713	CcSEcCtD
Cidofovir—Dermatitis—Bleomycin—lymphatic system cancer	0.000712	0.000712	CcSEcCtD
Cidofovir—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000711	0.000711	CcSEcCtD
Cidofovir—Asthenia—Carmustine—lymphatic system cancer	0.000708	0.000708	CcSEcCtD
Cidofovir—Renal failure—Methotrexate—lymphatic system cancer	0.000705	0.000705	CcSEcCtD
Cidofovir—Stomatitis—Methotrexate—lymphatic system cancer	0.000699	0.000699	CcSEcCtD
Cidofovir—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000697	0.000697	CcSEcCtD
Cidofovir—Hypersensitivity—Vincristine—lymphatic system cancer	0.000694	0.000694	CcSEcCtD
Cidofovir—Sweating—Methotrexate—lymphatic system cancer	0.000687	0.000687	CcSEcCtD
Cidofovir—Haematuria—Methotrexate—lymphatic system cancer	0.000684	0.000684	CcSEcCtD
Cidofovir—Epistaxis—Methotrexate—lymphatic system cancer	0.000676	0.000676	CcSEcCtD
Cidofovir—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000676	0.000676	CcSEcCtD
Cidofovir—Asthenia—Vincristine—lymphatic system cancer	0.000676	0.000676	CcSEcCtD
Cidofovir—Diarrhoea—Carmustine—lymphatic system cancer	0.000675	0.000675	CcSEcCtD
Cidofovir—Nausea—Bleomycin—lymphatic system cancer	0.000672	0.000672	CcSEcCtD
Cidofovir—Asthenia—Mitoxantrone—lymphatic system cancer	0.000658	0.000658	CcSEcCtD
Cidofovir—Dizziness—Carmustine—lymphatic system cancer	0.000653	0.000653	CcSEcCtD
Cidofovir—Diarrhoea—Vincristine—lymphatic system cancer	0.000645	0.000645	CcSEcCtD
Cidofovir—Hepatitis—Methotrexate—lymphatic system cancer	0.000644	0.000644	CcSEcCtD
Cidofovir—Pharyngitis—Methotrexate—lymphatic system cancer	0.000639	0.000639	CcSEcCtD
Cidofovir—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000636	0.000636	CcSEcCtD
Cidofovir—Urethral disorder—Methotrexate—lymphatic system cancer	0.000631	0.000631	CcSEcCtD
Cidofovir—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000628	0.000628	CcSEcCtD
Cidofovir—Vomiting—Carmustine—lymphatic system cancer	0.000628	0.000628	CcSEcCtD
Cidofovir—Dizziness—Vincristine—lymphatic system cancer	0.000623	0.000623	CcSEcCtD
Cidofovir—Rash—Carmustine—lymphatic system cancer	0.000622	0.000622	CcSEcCtD
Cidofovir—Dermatitis—Carmustine—lymphatic system cancer	0.000622	0.000622	CcSEcCtD
Cidofovir—Visual impairment—Methotrexate—lymphatic system cancer	0.00062	0.00062	CcSEcCtD
Cidofovir—Headache—Carmustine—lymphatic system cancer	0.000618	0.000618	CcSEcCtD
Cidofovir—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000608	0.000608	CcSEcCtD
Cidofovir—Eye disorder—Methotrexate—lymphatic system cancer	0.000601	0.000601	CcSEcCtD
Cidofovir—Tinnitus—Methotrexate—lymphatic system cancer	0.0006	0.0006	CcSEcCtD
Cidofovir—Vomiting—Vincristine—lymphatic system cancer	0.000599	0.000599	CcSEcCtD
Cidofovir—Rash—Vincristine—lymphatic system cancer	0.000594	0.000594	CcSEcCtD
Cidofovir—Dermatitis—Vincristine—lymphatic system cancer	0.000594	0.000594	CcSEcCtD
Cidofovir—Headache—Vincristine—lymphatic system cancer	0.00059	0.00059	CcSEcCtD
Cidofovir—Nausea—Carmustine—lymphatic system cancer	0.000586	0.000586	CcSEcCtD
Cidofovir—Angiopathy—Methotrexate—lymphatic system cancer	0.000584	0.000584	CcSEcCtD
Cidofovir—Vomiting—Mitoxantrone—lymphatic system cancer	0.000583	0.000583	CcSEcCtD
Cidofovir—Mediastinal disorder—Methotrexate—lymphatic system cancer	0.00058	0.00058	CcSEcCtD
Cidofovir—Rash—Mitoxantrone—lymphatic system cancer	0.000579	0.000579	CcSEcCtD
Cidofovir—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000578	0.000578	CcSEcCtD
Cidofovir—Chills—Methotrexate—lymphatic system cancer	0.000577	0.000577	CcSEcCtD
Cidofovir—Headache—Mitoxantrone—lymphatic system cancer	0.000575	0.000575	CcSEcCtD
Cidofovir—Alopecia—Methotrexate—lymphatic system cancer	0.000569	0.000569	CcSEcCtD
Cidofovir—Nausea—Vincristine—lymphatic system cancer	0.00056	0.00056	CcSEcCtD
Cidofovir—Dysgeusia—Methotrexate—lymphatic system cancer	0.000549	0.000549	CcSEcCtD
Cidofovir—Nausea—Mitoxantrone—lymphatic system cancer	0.000545	0.000545	CcSEcCtD
Cidofovir—Back pain—Methotrexate—lymphatic system cancer	0.000542	0.000542	CcSEcCtD
Cidofovir—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00052	0.00052	CcSEcCtD
Cidofovir—Anaemia—Methotrexate—lymphatic system cancer	0.000518	0.000518	CcSEcCtD
Cidofovir—Malaise—Methotrexate—lymphatic system cancer	0.000505	0.000505	CcSEcCtD
Cidofovir—Vertigo—Methotrexate—lymphatic system cancer	0.000503	0.000503	CcSEcCtD
Cidofovir—Leukopenia—Methotrexate—lymphatic system cancer	0.000501	0.000501	CcSEcCtD
Cidofovir—Cough—Methotrexate—lymphatic system cancer	0.000489	0.000489	CcSEcCtD
Cidofovir—Convulsion—Methotrexate—lymphatic system cancer	0.000485	0.000485	CcSEcCtD
Cidofovir—Chest pain—Methotrexate—lymphatic system cancer	0.000477	0.000477	CcSEcCtD
Cidofovir—Myalgia—Methotrexate—lymphatic system cancer	0.000477	0.000477	CcSEcCtD
Cidofovir—Arthralgia—Methotrexate—lymphatic system cancer	0.000477	0.000477	CcSEcCtD
Cidofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000474	0.000474	CcSEcCtD
Cidofovir—Discomfort—Methotrexate—lymphatic system cancer	0.000471	0.000471	CcSEcCtD
Cidofovir—Confusional state—Methotrexate—lymphatic system cancer	0.000461	0.000461	CcSEcCtD
Cidofovir—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000457	0.000457	CcSEcCtD
Cidofovir—Infection—Methotrexate—lymphatic system cancer	0.000454	0.000454	CcSEcCtD
Cidofovir—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000448	0.000448	CcSEcCtD
Cidofovir—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000448	0.000448	CcSEcCtD
Cidofovir—Skin disorder—Methotrexate—lymphatic system cancer	0.000444	0.000444	CcSEcCtD
Cidofovir—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000442	0.000442	CcSEcCtD
Cidofovir—Anorexia—Methotrexate—lymphatic system cancer	0.000436	0.000436	CcSEcCtD
Cidofovir—Hypotension—Methotrexate—lymphatic system cancer	0.000427	0.000427	CcSEcCtD
Cidofovir—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000417	0.000417	CcSEcCtD
Cidofovir—Insomnia—Methotrexate—lymphatic system cancer	0.000414	0.000414	CcSEcCtD
Cidofovir—Paraesthesia—Methotrexate—lymphatic system cancer	0.000411	0.000411	CcSEcCtD
Cidofovir—Dyspnoea—Methotrexate—lymphatic system cancer	0.000408	0.000408	CcSEcCtD
Cidofovir—Somnolence—Methotrexate—lymphatic system cancer	0.000406	0.000406	CcSEcCtD
Cidofovir—Dyspepsia—Methotrexate—lymphatic system cancer	0.000402	0.000402	CcSEcCtD
Cidofovir—Decreased appetite—Methotrexate—lymphatic system cancer	0.000397	0.000397	CcSEcCtD
Cidofovir—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000395	0.000395	CcSEcCtD
Cidofovir—Pain—Methotrexate—lymphatic system cancer	0.000391	0.000391	CcSEcCtD
Cidofovir—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000377	0.000377	CcSEcCtD
Cidofovir—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000374	0.000374	CcSEcCtD
Cidofovir—Urticaria—Methotrexate—lymphatic system cancer	0.000363	0.000363	CcSEcCtD
Cidofovir—Abdominal pain—Methotrexate—lymphatic system cancer	0.000361	0.000361	CcSEcCtD
Cidofovir—Body temperature increased—Methotrexate—lymphatic system cancer	0.000361	0.000361	CcSEcCtD
Cidofovir—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000337	0.000337	CcSEcCtD
Cidofovir—Asthenia—Methotrexate—lymphatic system cancer	0.000328	0.000328	CcSEcCtD
Cidofovir—Pruritus—Methotrexate—lymphatic system cancer	0.000323	0.000323	CcSEcCtD
Cidofovir—Diarrhoea—Methotrexate—lymphatic system cancer	0.000313	0.000313	CcSEcCtD
Cidofovir—Dizziness—Methotrexate—lymphatic system cancer	0.000302	0.000302	CcSEcCtD
Cidofovir—Vomiting—Methotrexate—lymphatic system cancer	0.000291	0.000291	CcSEcCtD
Cidofovir—Rash—Methotrexate—lymphatic system cancer	0.000288	0.000288	CcSEcCtD
Cidofovir—Dermatitis—Methotrexate—lymphatic system cancer	0.000288	0.000288	CcSEcCtD
Cidofovir—Headache—Methotrexate—lymphatic system cancer	0.000286	0.000286	CcSEcCtD
Cidofovir—Nausea—Methotrexate—lymphatic system cancer	0.000272	0.000272	CcSEcCtD
